Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 153
9
Diseases
89
Unique genes
0.213
Avg. similarity score
Congestive ophthalmopathy
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Congestive ophthalmopathy
Graves ophthalmopathy
Myopathic ophthalmopathy
Graft-versus-host disease
Granulomatosis with polyangiitis
T-cell leukemia-lymphoma
Anorexia
HELIOS deficiency
gray platelet syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congestive ophthalmopathy | 6 | 6 | 13 |
| Graves ophthalmopathy | 6 | 6 | 18 |
| Myopathic ophthalmopathy | 6 | 6 | 13 |
| Graft-versus-host disease | 5 | 5 | 21 |
| Granulomatosis with polyangiitis | 4 | 4 | 14 |
| T-cell leukemia-lymphoma | 4 | 4 | 36 |
| Anorexia | 3 | 3 | 18 |
| HELIOS deficiency | 1 | 1 | 1 |
| gray platelet syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CTLA4 | 6 / 9 | Congestive ophthalmopathy, Graft-versus-host disease, Granulomatosis with polyangiitis, Graves ophthalmopathy and 2 more |
| IL10 | 6 / 9 | Congestive ophthalmopathy, Graft-versus-host disease, Granulomatosis with polyangiitis, Graves ophthalmopathy and 2 more |
| IL2 | 6 / 9 | Anorexia, Congestive ophthalmopathy, Graft-versus-host disease, Graves ophthalmopathy and 2 more |
| IL1RN | 5 / 9 | Anorexia, Congestive ophthalmopathy, Graft-versus-host disease, Graves ophthalmopathy and 1 more |
| PTPN22 | 5 / 9 | Congestive ophthalmopathy, Graft-versus-host disease, Granulomatosis with polyangiitis, Graves ophthalmopathy and 1 more |
| TNF | 4 / 9 | Anorexia, Congestive ophthalmopathy, Graves ophthalmopathy, Myopathic ophthalmopathy |
| CA1 | 3 / 9 | Congestive ophthalmopathy, Graves ophthalmopathy, Myopathic ophthalmopathy |
| ICAM1 | 3 / 9 | Congestive ophthalmopathy, Graves ophthalmopathy, Myopathic ophthalmopathy |
| IL23R | 3 / 9 | Congestive ophthalmopathy, Graves ophthalmopathy, Myopathic ophthalmopathy |
| IL3 | 3 / 9 | Congestive ophthalmopathy, Graves ophthalmopathy, Myopathic ophthalmopathy |
| PTGS2 | 3 / 9 | Congestive ophthalmopathy, Graves ophthalmopathy, Myopathic ophthalmopathy |
| SCD | 3 / 9 | Congestive ophthalmopathy, Graves ophthalmopathy, Myopathic ophthalmopathy |
| TSHR | 3 / 9 | Congestive ophthalmopathy, Graves ophthalmopathy, Myopathic ophthalmopathy |
| HLA-DPB1 | 2 / 9 | Graft-versus-host disease, Granulomatosis with polyangiitis |
| IFNA2 | 2 / 9 | Anorexia, T-cell leukemia-lymphoma |
| IFNG | 2 / 9 | Graft-versus-host disease, T-cell leukemia-lymphoma |
| IKZF2 | 2 / 9 | HELIOS deficiency, T-cell leukemia-lymphoma |
| NBEAL2 | 2 / 9 | Graves ophthalmopathy, gray platelet syndrome |
| TNFSF8 | 2 / 9 | Graft-versus-host disease, T-cell leukemia-lymphoma |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Inflammatory bowel disease | KEGG | 15 / 66 | 30.7× | 6.44e-19 | 4.42e-16 ✓ sig. |
| Cytokine-cytokine receptor interaction | KEGG | 22 / 298 | 10.0× | 2.01e-16 | 8.76e-14 ✓ sig. |
| Interleukin-10 signaling | Reactome | 11 / 47 | 31.6× | 2.74e-14 | 7.77e-12 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 14 / 108 | 17.5× | 4.16e-14 | 1.12e-11 ✓ sig. |
| Leishmaniasis | KEGG | 12 / 78 | 20.8× | 3.72e-13 | 8.64e-11 ✓ sig. |
| Th17 cell differentiation | KEGG | 13 / 109 | 16.1× | 1.08e-12 | 2.36e-10 ✓ sig. |
| Autoimmune thyroid disease | KEGG | 10 / 54 | 25.0× | 5.45e-12 | 1.03e-9 ✓ sig. |
| Tuberculosis | KEGG | 14 / 181 | 10.4× | 5.37e-11 | 8.20e-9 ✓ sig. |
| T cell receptor signaling pathway | KEGG | 12 / 122 | 13.3× | 8.56e-11 | 1.25e-8 ✓ sig. |
| Natural killer cell mediated cytotoxicity | KEGG | 12 / 133 | 12.2× | 2.37e-10 | 3.13e-8 ✓ sig. |
| Allograft rejection | KEGG | 8 / 39 | 27.7× | 3.37e-10 | 4.31e-8 ✓ sig. |
| Type I diabetes mellitus | KEGG | 8 / 44 | 24.5× | 9.41e-10 | 1.06e-7 ✓ sig. |
| Graft-versus-host disease | KEGG | 8 / 45 | 24.0× | 1.14e-9 | 1.26e-7 ✓ sig. |
| Rheumatoid arthritis | KEGG | 10 / 95 | 14.2× | 1.80e-9 | 1.87e-7 ✓ sig. |
| NF-kappa B signaling pathway | KEGG | 10 / 105 | 12.9× | 4.84e-9 | 4.61e-7 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| immune response | GO:0006955 | 32 / 543 | 12.4× | 9.00e-27 | 3.35e-23 ✓ sig. |
| inflammatory response | GO:0006954 | 19 / 467 | 8.5× | 5.67e-13 | 2.74e-10 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 25 / 1,208 | 4.3× | 2.19e-10 | 5.78e-8 ✓ sig. |
| humoral immune response | GO:0006959 | 8 / 58 | 29.0× | 3.03e-10 | 7.74e-8 ✓ sig. |
| cell surface receptor signaling pathway | GO:0007166 | 14 / 373 | 7.9× | 2.46e-9 | 4.96e-7 ✓ sig. |
| cell surface receptor signaling pathway via STAT | GO:0097696 | 6 / 28 | 45.0× | 3.41e-9 | 6.63e-7 ✓ sig. |
| positive regulation of cell population proliferation | GO:0008284 | 16 / 532 | 6.3× | 3.86e-9 | 7.41e-7 ✓ sig. |
| positive regulation of T cell proliferation | GO:0042102 | 7 / 67 | 21.9× | 3.02e-8 | 4.41e-6 ✓ sig. |
| positive regulation of ERK1 and ERK2 cascade | GO:0070374 | 10 / 201 | 10.4× | 4.03e-8 | 5.64e-6 ✓ sig. |
| negative regulation of inflammatory response | GO:0050728 | 9 / 152 | 12.4× | 4.49e-8 | 6.18e-6 ✓ sig. |
| positive regulation of interleukin-10 production | GO:0032733 | 6 / 43 | 29.3× | 5.21e-8 | 7.02e-6 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 9 / 161 | 11.7× | 7.37e-8 | 9.33e-6 ✓ sig. |
| positive regulation of type II interferon production | GO:0032729 | 7 / 77 | 19.1× | 8.03e-8 | 1.00e-5 ✓ sig. |
| signal transduction | GO:0007165 | 29 / 2,125 | 2.9× | 8.14e-8 | 1.01e-5 ✓ sig. |
| T cell receptor signaling pathway | GO:0050852 | 8 / 121 | 13.9× | 1.12e-7 | 1.32e-5 ✓ sig. |